132 related articles for article (PubMed ID: 22024784)
21. Association of vitamin K deficiency with bone metabolism and clinical disease activity in inflammatory bowel disease.
Nakajima S; Iijima H; Egawa S; Shinzaki S; Kondo J; Inoue T; Hayashi Y; Ying J; Mukai A; Akasaka T; Nishida T; Kanto T; Tsujii M; Hayashi N
Nutrition; 2011 Oct; 27(10):1023-8. PubMed ID: 21482072
[TBL] [Abstract][Full Text] [Related]
22. [Bone mineral density in inflammatory bowel diseases in children].
Szumera M; Landowski P; Kamińska B; Góra-Gebka M; Popadiuk S; Renke J
Med Wieku Rozwoj; 2006; 10(2):445-51. PubMed ID: 16825715
[TBL] [Abstract][Full Text] [Related]
23. Frequency of low bone mineral density in Saudi patients with inflammatory bowel disease.
Ismail MH; Al-Elq AH; Al-Jarodi ME; Azzam NA; Aljebreen AM; Al-Momen SA; Bseiso BF; Al-Mulhim FA; Alquorain A
Saudi J Gastroenterol; 2012; 18(3):201-7. PubMed ID: 22626800
[TBL] [Abstract][Full Text] [Related]
24. [The risk factor for low bone mineral density in patients with inflammatory bowel disease].
Liu JB; Gao X; Zhang FB; Yang L; Xiao YL; Zhang RD; Li ZP; Hu PJ; Chen MH
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):833-6. PubMed ID: 20079225
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2002 Feb; 37(2):192-9. PubMed ID: 11843057
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density in patients with pancreatic insufficiency and steatorrhea.
Morán CE; Sosa EG; Martinez SM; Geldern P; Messina D; Russo A; Boerr L; Bai JC
Am J Gastroenterol; 1997 May; 92(5):867-71. PubMed ID: 9149203
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease has a small effect on bone mineral density and risk for osteoporosis.
Targownik LE; Bernstein CN; Nugent Z; Leslie WD
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):278-85. PubMed ID: 23103821
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral assessment by dual energy X-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area.
Ahmed SF; Horrocks IA; Patterson T; Zaidi S; Ling SC; McGrogan P; Weaver LT
J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):276-80. PubMed ID: 15076625
[TBL] [Abstract][Full Text] [Related]
30. Should COPD patients be routinely evaluated for bone mineral density?
Karadag F; Cildag O; Yurekli Y; Gurgey O
J Bone Miner Metab; 2003; 21(4):242-6. PubMed ID: 12811630
[TBL] [Abstract][Full Text] [Related]
31. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
32. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 6, osteoprotegerin, sRANKL and bone metabolism in inflammatory bowel diseases.
Krela-Kaźmierczak I; Szymczak-Tomczak A; Łykowska-Szuber L; Wysocka E; Michalak M; Stawczyk-Eder K; Waszak K; Linke K; Eder P
Adv Clin Exp Med; 2018 Apr; 27(4):449-453. PubMed ID: 29558031
[TBL] [Abstract][Full Text] [Related]
34. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
[TBL] [Abstract][Full Text] [Related]
35. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density and body composition in ulcerative colitis: a six-year follow-up.
Ulivieri FM; Piodi LP; Taioli E; Lisciandrano D; Ranzi T; Vezzoli M; Cermesoni L; Bianchi P
Osteoporos Int; 2001; 12(5):343-8. PubMed ID: 11444080
[TBL] [Abstract][Full Text] [Related]
37. Evidence for inflammation-induced bone loss in non-radiographic axial spondyloarthritis.
Akgöl G; Kamanlı A; Ozgocmen S
Rheumatology (Oxford); 2014 Mar; 53(3):497-501. PubMed ID: 24262756
[TBL] [Abstract][Full Text] [Related]
38. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
[TBL] [Abstract][Full Text] [Related]
39. Bone mineral density and body composition in patients with ulcerative colitis.
Ulivieri FM; Lisciandrano D; Ranzi T; Taioli E; Cermesoni L; Piodi LP; Nava MC; Vezzoli M; Bianchi PA
Am J Gastroenterol; 2000 Jun; 95(6):1491-4. PubMed ID: 10894585
[TBL] [Abstract][Full Text] [Related]
40. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
